Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of. Mr. Sandoval’s appointment comes as Milestone launches CARDAMYST™ (etripamil) nasal spray, the first and only approved ...
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of David Sandoval as General Counsel and Chief Compliance ...
Researchers are exploring a new generation of biochemical markers that may help clinicians detect myocardial contusion, a frequently overlooked form of heart injury caused by blunt chest trauma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results